Provided by Tiger Fintech (Singapore) Pte. Ltd.

Insulet

305.66
-6.1100-1.96%
Post-market: 306.000.3400+0.11%17:35 EDT
Volume:912.97K
Turnover:279.71M
Market Cap:21.51B
PE:55.09
High:312.00
Open:310.40
Low:302.69
Close:311.77
Loading ...

Insulet Issues Redemption Notice for Convertible Notes

TIPRANKS
·
1 hour ago

Insulet Corp. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
1 hour ago

Insulet Corp - Enters Eighth Amendment to Credit Agreement - SEC Filing

THOMSON REUTERS
·
1 hour ago

Insulet Corp - Replaces $481.25 Mln Term Loans With New Term Loans - SEC Filing

THOMSON REUTERS
·
1 hour ago

Insulet Corporation Refinances $481 Million in Term Loans with Amended Credit Agreement, Reduces Interest Rate Margins

Reuters
·
1 hour ago

Healthcare companies are hiring. Is it time to look for growth stocks in this beaten-down sector?

Dow Jones
·
07 Jun

Insulet Corp. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
05 Jun

Insulet Corp : TD Cowen Raises Target Price to $379 From $324

THOMSON REUTERS
·
04 Jun

Insulet Initiated at Buy by Goldman Sachs

Dow Jones
·
31 May

S&P 500 Set for Best May Since 1990! Nvidia & Tesla Among Top 10 Performers with 27%+ Gains

Tiger Newspress
·
30 May

Insulet initiated with a Buy at Goldman Sachs

TIPRANKS
·
30 May

Insulet Corporation Holds 2025 Annual Stockholders Meeting

TIPRANKS
·
29 May

Insulet Corporation Conducted Annual Shareholder Meeting

Reuters
·
29 May

Insulet Corp. Stock Rises Tuesday, Still Underperforms Market

Dow Jones
·
28 May

Raymond James Adjusts Price Target on Insulet to $360 From $328, Maintains Outperform Rating

MT Newswires Live
·
27 May

Insulet Corporation to Present at Goldman Sachs 46th Annual Global Healthcare Conference 2025

Reuters
·
23 May

Insulet Corp. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
23 May

Insulet Is Maintained at Buy by Citigroup

Dow Jones
·
23 May

Analysts Offer Insights on Healthcare Companies: Insulet (PODD), Waters (WAT) and Anebulo Pharmaceuticals (ANEB)

TIPRANKS
·
22 May

Citigroup Adjusts Price Target on Insulet to $380 From $320, Maintains Buy Rating

MT Newswires Live
·
22 May